Endovascular treatment of subarachnoid hemorrhage.
Aneurysmal subarachnoid hemorrhage (aSAH) is a common and devastating form of stroke. A large number of patients with aSAH develop angiographic or clinical vasospasm responsible for high morbidity and mortality. Rapid advances in the field of interventional neurology and the development of minimally invasive techniques have resulted in expansion of potential therapeutic applications. Treatment of aSAH has benefited from this rapid advance in the field of endovascular therapies. In the first section of the review, we discuss the therapeutic options and techniques for embolizations of intracranial aneurysms. In the second section, we discuss evolving endovascular treatment methods employed to intervene in delayed complications of cerebral vasospasm in patients with aSAH.
Kirmani
Jawad F
JF
Zeenat Qureshi Stroke Research Center, Department of Neurology and Neurosciences, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA. kirmanjf@umdnj.edu
Alkawi
Ammar
A
Ahmed
Shafiuddin
S
Janjua
Nazli
N
Khatri
Ismail
I
Divani
Afshin A
AA
Qureshi
Adnan I
AI
D000800:Angioplasty, Balloon; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006801:Humans; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D016019:Survival Analysis
D002121:Calcium Channel Blockers